ask="4.50"
ask_size="1000"
average_daily_volume="55723"
bid="1.25"
bid_size="500"
book_value="1.19"
change="-0.11"
change_from_200_day_moving_average="-1.12"
change_from_50_day_moving_average="-0.25"
change_from_52_week_high="-3.53"
change_From_52_week_low="0.37"
change_in_percent="-3.55%"
close="2.99"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.90"
ebitda="-15.74M"
eps_estimate_current_year="-3.71"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.81"
ex_dividend_date="N/A"
float_shares="5652000"
high="3.10"
high_52_weeks="6.52"
last_trade_date="2/6/2017"
last_trade_price="2.99"
last_trade_size="100"
last_trade_time="4:00pm"
low="2.97"
low_52_weeks="2.62"
market_capitalization="18.83M"
moving_average_200_day="4.11"
moving_average_50_day="3.24"
name="MABVAX THERAPEUTICS"
notes="N/A"
one_year_target_price="18.00"
open="3.10"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-27.30%"
percent_change_from_50_day_moving_average="-7.80%"
percent_change_from_52_week_high="-54.13%"
percent_change_from_52_week_low="+14.12%"
previous_close="3.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.60"
price_per_sales="21.55"
revenue="905615.00"
shares_outstanding="6296000"
short_ratio="7.95"
stock_exchange="NCM"
symbol="MBVX"
volume="10344"
weeks_range_52="2.62 - 6.52"
